Key facts
- This page summarizes Daniel J. Brennan's Form 4 filing for VERTEX PHARMACEUTICALS INC / MA (VRTX).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 22 Oct 2026, 16:10.
Daniel J. Brennan - 20 Oct 2026 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)
- Reporting relationship
- Director
- Issuer ticker
- VRTX
- Reported as of
- 20 Oct 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 22 Oct 2026, 16:10:59 UTC
- Prior SEC filing
- 18 Jun 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Christiana Stevenson, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
Daniel J. Brennan filed Form 4 for VERTEX PHARMACEUTICALS INC / MA (VRTX) on 22 Oct 2026.
Change
- Previous filing in this sequence was filed on 18 Jun 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001595612
Primary reporting owner
Brennan Daniel J.
- Relationship
- Director
- Address
- C/O VERTEX PHARMACEUTICALS INCORPORATED, 50 NORTHERN AVENUE, BOSTON
- Signature
- /s/ Christiana Stevenson, Attorney-in-Fact
- Signature date
- 22 Oct 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
VRTX
transaction
Common Stock
Award
- Transaction value
- Shares
- +795
- Change %
- Price
- $503.47*
- Shares after
- 795
- Date
- 20 Oct 2026
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date.